The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2022 | The importance of studying the genetic landscape of myeloid malignancies
Enrico Attardi, MD, University of Rome Tor Vergata, Rome Italy, discusses the clinical implications related to the identification of inherited predisposition to myeloid malignancies such as myelodysplastic syndromes (MDS). Knowledge of these germline variants can be used for genetic counseling, but also to help understand the biology of the disease, and to personalize treatment. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
